Oxford Science Enterprises signs deal with Lothbury to develop state-of-the-art R&D facilities in Oxford city center


OXFORD, England, March 14, 2022 /PRNewswire/ — Oxford Science Enterprises, the science-based business builder and preferred investment partner of the University of Oxfordannounces that it has entered into a joint venture with the Lothbury Property Trust (“Lothbury”) to develop high specification laboratories and offices, for life science start-ups, in the heart of Oxford downtown.

The 30,000 square foot R&D space is part of a comprehensive £200 million redevelopment project of the Clarendon Centre. Led by Lothbury, the redevelopment is expected to begin in 2022, pending required approvals. When completed, expected in 2024, the R&D space will provide an ideal environment for fast-growing life science companies, including those founded by Oxford Science Enterprises. In addition to R&D facilities, plans for the entire 250,000 square foot site include the creation of space for student housing, offices, retail outlets and restaurants.

In Oxford, the demand for laboratory space is about ten times greater than the existing supply. With over 100 companies in its portfolio, Oxford Science Enterprises has an ever-increasing need for specialist laboratories and office space. Clarendon Center redevelopment will significantly increase Oxford Science Enterprises’ existing 55,000 square foot footprint in and around Oxford and improve its ability to provide its businesses with the essential facilities needed to grow and prosper.

Alexis DormandyCEO of Oxford Science Enterprises, said: “There is a severe shortage of labs and office space that meets the specific needs of life science start-ups in Oxford. This new joint venture with Lothbury supports our strategy of being a comprehensive science-based business builder, providing not only investment backed by strategic and operational expertise, but also essential R&D space to support the growth of our businesses in the early stages. of development.

“We believe the city center location will prove attractive to new businesses and provide fledgling biotechs with access to state-of-the-art facilities while remaining close to the University, its entrepreneurs and academics. This is an exciting evolution of the space and the city center, bringing new life and opportunity to the high street and local businesses.”

Simon RadfordCEO Lothbury Investment Management Limited added:

“This is a major investment for Lothbury, which has owned the Clarendon Center since its inception in 1985 and brings Lothbury investors into the exciting new areas of life sciences and biomedical real estate. The joint venture with Oxford Science Enterprises is the first tenancy within a comprehensive redevelopment project, which is expected to be implemented in stages. The proposed development will comprise four highly sustainable buildings, bringing office, laboratory and student accommodation to the heart of Oxford downtown.”

About Oxford Science Enterprises

We are Oxford Science Enterprises, the builder of science enterprises. We want to help solve the world’s toughest problems for more people, in more places, faster. We do this by transforming cutting-edge science into world-changing companies, pairing the best scientists from the world’s best university with the best minds in business. We develop our businesses with care and expertise; in a systematic and progressive way. We invest for real impact, not just financial returns. And we reinvest the profits in the next generation of original research and world-changing companies.

Our companies tackle issues that affect people in ways that change their lives: their health, the availability of food, the survival of the planet. Since 2015, we have received automatic participation in all Oxford University scientific impact – more than 100 companies founded by more than 200 of from Oxford leading academics. We have played a leading role in the creation and construction of more 70 of these, adding +55,000 square feet of lab and boot space to support them. Today our companies are worth more £2 billion and have created +2,000 works.

Follow us: oxfordscienceenterprises.com | Twitter | LinkedIn | Quarterly News

About Lothbury Investment Management Limited

Lothbury Investment Management Limited (LIM) is a UK property investment manager with £2 billion in assets under management, as of the fourth quarter of 2021.

Lothbury Property Trust (LPT) is LIM’s flagship fund, providing investors with access to the UK property market. Lothbury Property Trust holds £1.64 billion in assets under management and is a balanced property unit trust offering exposure to the UK office, retail, industrial, student accommodation and hospitality sectors and is geographically spread across the UK.

The Fund offers an innovative investment solution through a core/active strategy that includes a primarily core portfolio of blue chip assets to achieve yield stability, combined with active management initiatives to create additional value and improved return for the investor.

More information about LIM and LPT can be found at www.lothburyim.com

Lothbury Investment Management Limited is authorized and regulated by the Financial Conduct Authority.


Oxford Scientific Enterprises
Lisa Bedwell[email protected]

For media inquiries:
swallow mark, Sandi Greenwood, Eleanor Perkin – MEDISTRVA Consulting
[email protected]

Lothbury Investment Management Limited

For media inquiries:
Pierre TreglownFOUR PR
01603 627294, [email protected]

SOURCEOxford Science Enterprises


Comments are closed.